Of particular significance, fecal-derived EVs (fEVs) from CRC patients elevated expression of specific proteins biomarkers, including the transmembrane glycoproteins A33 (also known as GPA33) and CD147 (basigin). The gene discussed is GPA33; the disease is colorectal carcinoma.